Evidence map›Paper›PMID 34884711›Full record

ArticleInternational journal of molecular sciences2021

Target Characterization of Kaempferol against Myocardial Infarction Using Novel In Silico Docking and DARTS Prediction Strategy.

Xunxun Wu, Xiaokun Li, Chunxue Yang, Yong Diao

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xunxun WuSchool of Biomedical Science, Huaqiao University, Quanzhou 362021, China.ORCID 0000-0003-1536-634X
Xiaokun LiSchool of Biomedical Science, Huaqiao University, Quanzhou 362021, China.
Chunxue YangDepartment of Pathology, The University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0003-4842-9044
Yong DiaoSchool of Biomedical Science, Huaqiao University, Quanzhou 362021, China.ORCID 0000-0002-0633-1906

Funding

The Natural Science Foundation of Fujian Province of China 2018J01127The Science and the Technology Planning Projects of Quanzhou Municipal 2019N031the Scientific Research Funds of Huaqiao University 21BS126
6 · The paper itself

Abstract

Target identification is a crucial process for advancing natural products and drug leads development, which is often the most challenging and time-consuming step. However, the putative biological targets of natural products obtained from traditional prediction studies are also informatively redundant. Thus, how to precisely identify the target of natural products is still one of the major challenges. Given the shortcomings of current target identification methodologies, herein, a novel in silico docking and DARTS prediction strategy was proposed. Concretely, the possible molecular weight was detected by DARTS method through examining the protected band in SDS-PAGE. Then, the potential targets were obtained from screening and identification through the PharmMapper Server and TargetHunter method. In addition, the candidate target Src was further validated by surface plasmon resonance assay, and the anti-apoptosis effects of kaempferol against myocardial infarction were further confirmed by in vitro and in vivo assays. Collectively, these results demonstrated that the integrated strategy could efficiently characterize the targets, which may shed a new light on target identification of natural products.

Indexed as

AnimalsComputer SimulationDrug DiscoveryKaempferolsMaleMolecular Docking SimulationMyocardial InfarctionMyocytes, CardiacRatsRats, Sprague-DawleySoftwaresrc-Family KinaseskaempferolKaempferolssrc-Family KinasesDARTSdockingkaempferolSrctarget identification

Identifiers

PMID34884711
PMCPMC8657499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.